Sigma-Aldrich Reorganizes Chemical Business.
Sigma-Aldrich stock has been down recently and this reorganization is an attempt to reinvigorate the company. It hopes to restore sales and profit growth to more than 10% per year within the next two years. By orienting its focus towards global markets, new product development, the Internet and the pharmaceutical industry, the company hopes to take advantage of growing markets. Sale of its metals business further reflects its more narrow focus on life science, laboratory, fine chemical and diagnostic customers.
|Printer friendly Cite/link Email Feedback|
|Publication:||Instrument Business Outlook|
|Date:||Nov 30, 1999|
|Previous Article:||Agilent Begins Trading.|
|Next Article:||Danaher Acquires Buhler Montec from Servomex plc.|